Top Stories Corvus Pharmaceuticals Stock Rises Following Positive Eczema Trial Results Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) witnessed a significant surge in its stock price on January 15, 2026, following the release of promising data from cohort... Editorial20 January, 2026